pmc logo imageJournal ListSearchpmc logo image
Logo of amjphAmerican Journal of Public Health Web SiteAmerican Public Health Association Web SiteSubmissionsSubscriptionsAbout Us
Am J Public Health. 1991 May; 81(5): 563–567.
PMCID: PMC1405068
Cuba's response to the HIV epidemic.
E J Pérez-Stable
Department of Medicine, University of California, San Francisco 94143-0320.
Abstract
BACKGROUND: Cuba's response to the human immunodeficiency virus (HIV) epidemic has been to conduct mass testing of the population to ascertain seroprevalence, to enforce mandatory relative quarantine of persons testing positive, and to implement educational interventions using media and school-based programs. METHODS: Interview with the Vice-Minister of Health and review of available data. RESULTS: Reports to date show a very low seroprevalence rate without evidence of a widespread epidemic. Sexual contact with foreign-born persons is the primary risk factor. Possible advantages of Cuba's policy include rapid reduction in the risk of HIV transmission by infected blood products, an opportunity for focused education and secondary prevention, and limitation of new infections. Possible disadvantages include the restriction of individual freedom in those who are not guilty of any illegal act, quarantine of persons with false positive HIV tests, and ongoing transmission because of the incomplete nature of the quarantine. The policy is expensive and may displace other public health priorities. The content of the media-based educational interventions has emphasized rational medical information in unimaginative formats with a limited focus on prevention. CONCLUSIONS: The issue of personal responsibility for behavioral change versus government imposed regulations is at the core of Cuba's HIV policy. The quarantine policy may paradoxically permit most Cubans to feel that they are personally invulnerable to the HIV epidemic.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Bayer, R; Healton, C. Controlling AIDS in Cuba. The logic of quarantine. N Engl J Med. 1989 Apr 13;320(15):1022–1024. [PubMed]
  • Pérez-Stable, EJ; Pedraza, RO. Tuberculosis in Cuba. Am Rev Respir Dis. 1984 Sep;130(3):520–523. [PubMed]
  • High-tech medicine in the Caribbean: 25 years of Cuban health care. N Engl J Med. 1984 Jul 5;311(1):60–61. [PubMed]
  • Pérez-Stable, EJ. Community medicine in Cuba. J Community Psychol. 1985 Apr;13(2):124–137. [PubMed]
  • Roemer, MI. Health development and political policy: the lesson of Cuba. J Health Polit Policy Law. 1980 4(4):570–578.Winter; [PubMed]
  • Navarro, V. Health, health services, and health planning in Cuba. Int J Health Serv. 1972 Aug;2(3):397–432. [PubMed]
  • Ubell, RN. High-tech medicine in the Caribbean. 25 years of Cuban health care. N Engl J Med. 1983 Dec 8;309(23):1468–1472. [PubMed]
  • Conover, S; Donovan, S; Susser, E. Reflections on health care in Cuba. Lancet. 1980 Nov 1;2(8201):958–960. [PubMed]
  • Guttmacher, S. The prevention of health risks in Cuba. Int J Health Serv. 1987;17(1):179–189. [PubMed]
  • Kates, N. Mental health services in Cuba. Hosp Community Psychiatry. 1987 Jul;38(7):755–758. [PubMed]
  • Gordon, AM; Paya, R. Controlling AIDS in Cuba. N Engl J Med. 1989 Sep 21;321(12):829–830. [PubMed]
  • de Medina, M; Fletcher, MA; Valledor, MD; Ashman, M; Gordon, AM; Schiff, ER. Serological evidence for HIV infection in Cuban immigrants in 1980. Lancet. 1987 Jul 18;2(8551):166. [PubMed]
  • Mills, M; Wofsy, CB; Mills, J. The acquired immunodeficiency syndrome. Infection control and public health law. N Engl J Med. 1986 Apr 3;314(14):931–936. [PubMed]
  • Cates, W, Jr; Bowen, GS. Education for AIDS prevention: not our only voluntary weapon. Am J Public Health. 1989 Jul;79(7):871–874. [PubMed]
  • Volberding, PA; Lagakos, SW; Koch, MA; Pettinelli, C; Myers, MW; Booth, DK; Balfour, HH, Jr; Reichman, RC; Bartlett, JA; Hirsch, MS, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med. 1990 Apr 5;322(14):941–949. [PubMed]
  • Lo, B; Steinbrook, RL; Cooke, M; Coates, TJ; Walters, EJ; Hulley, SB. Voluntary screening for human immunodeficiency virus (HIV) infection. Weighing the benefits and harms. Ann Intern Med. 1989 May 1;110(9):727–733. [PubMed]
  • Marin, BV. AIDS prevention for non-Puerto Rican Hispanics. NIDA Res Monogr. 1990;93:35–52. [PubMed]
  • Peterson, JL; Marín, G. Issues in the prevention of AIDS among black and Hispanic men. Am Psychol. 1988 Nov;43(11):871–877. [PubMed]
  • Tesh, S. Health education in Cuba: a preface. Int J Health Serv. 1986;16(1):87–104. [PubMed]
  • Leads from the MMWR. Recent trends in tobacco consumption--Canada and other countries. JAMA. 1984 Jul 6;252(1):23–24. [PubMed]